Skip to main content
Fig. 1 | BMC Medical Research Methodology

Fig. 1

From: A graphical approach to assess the goodness-of-fit of random-effects linear models when the goal is to measure individual benefits of medical treatments in severely ill patients

Fig. 1

Selected p × 100% percentiles of the probability distribution of individual benefits of imipramine treatment as functions of treatment duration in patients with nonendogenous diagnosis (left panels; a, b) and endogenous diagnosis (right panels; c, d), estimated with two different methods, for p= 0.1, 0.25, 0.5, 0.6, 0.7, 0.75, 0.8, 0.85, 0.90, 0.95. Upper panels (a, c): percentiles estimated with Eq. (3) which assumes normality for the random effects. Lower panels (b, d): sample percentiles of EB predictors of individual benefits

Back to article page

BMC Medical Research Methodology

ISSN: 1471-2288

Contact us